@mehrankr.bsky.social
Reposted
💥New Publication Alert in Clinical Cancer Research💥
We are thrilled to announce our latest publication on our novel RNA and generative AI liquid biopsy platform for early colorectal cancer detection. #EarlyDetection #LiquidBiopsy #RNA
Read the full publication here: aacrjournals.org/clincancerre...
We are thrilled to announce our latest publication on our novel RNA and generative AI liquid biopsy platform for early colorectal cancer detection. #EarlyDetection #LiquidBiopsy #RNA
Read the full publication here: aacrjournals.org/clincancerre...
Detection of Early-Stage Colorectal Cancer Using Cell-Free oncRNA Biomarkers and Artificial Intelligence
Abstract. Purpose: Colorectal cancer (CRC) is the second leading cause of cancer-related deaths worldwide, and early detection significantly improves treatment outcomes, but existing blood-based tests...
aacrjournals.org
May 15, 2025 at 5:45 PM
💥New Publication Alert in Clinical Cancer Research💥
We are thrilled to announce our latest publication on our novel RNA and generative AI liquid biopsy platform for early colorectal cancer detection. #EarlyDetection #LiquidBiopsy #RNA
Read the full publication here: aacrjournals.org/clincancerre...
We are thrilled to announce our latest publication on our novel RNA and generative AI liquid biopsy platform for early colorectal cancer detection. #EarlyDetection #LiquidBiopsy #RNA
Read the full publication here: aacrjournals.org/clincancerre...
Reposted
Check out our latest work on one of the first multi-modal cell-free RNA foundation models for blood surveillance and liquid biopsy applications, led by @genophoria.bsky.social, @babak-a.bsky.social, @mehrankr.bsky.social and Aiden Sababi
Joining forces with the legendary @babak-a.bsky.social, @fhormozd.bsky.social, and @mkarimzadeh.bsky.social to bring you Exai-1; a multi-modal cell-free RNA foundation model for blood surveillance and liquid biopsy applications. Kudos to the broader @exai.bio team!
www.biorxiv.org/content/10.1...
www.biorxiv.org/content/10.1...
A multi-modal cell-free RNA language model for liquid biopsy applications
Cell-free RNA (cfRNA) profiling has emerged as a powerful tool for non-invasive disease detection, but its application is limited by data sparsity and complexity, especially in settings with constrain...
www.biorxiv.org
April 1, 2025 at 10:51 PM
Check out our latest work on one of the first multi-modal cell-free RNA foundation models for blood surveillance and liquid biopsy applications, led by @genophoria.bsky.social, @babak-a.bsky.social, @mehrankr.bsky.social and Aiden Sababi
Reposted
Super excited to share that our paper on a multi-modal cell-free RNA foundation model is out! A fantastic collaboration with @genophoria.bsky.social, @fhormozd.bsky.social and the @exai.bio team!
Joining forces with the legendary @babak-a.bsky.social, @fhormozd.bsky.social, and @mkarimzadeh.bsky.social to bring you Exai-1; a multi-modal cell-free RNA foundation model for blood surveillance and liquid biopsy applications. Kudos to the broader @exai.bio team!
www.biorxiv.org/content/10.1...
www.biorxiv.org/content/10.1...
A multi-modal cell-free RNA language model for liquid biopsy applications
Cell-free RNA (cfRNA) profiling has emerged as a powerful tool for non-invasive disease detection, but its application is limited by data sparsity and complexity, especially in settings with constrain...
www.biorxiv.org
April 1, 2025 at 10:30 PM
Super excited to share that our paper on a multi-modal cell-free RNA foundation model is out! A fantastic collaboration with @genophoria.bsky.social, @fhormozd.bsky.social and the @exai.bio team!
1/ It has been a privilege to have the opportunity of contributing to Exai-1. Shout out to my co-first author,
Aiden Sabadbi, and my amazing colleagues @exai.bio, particularly @fhormozd.bsky.social, @babak-a.bsky.social, and @genophoria.bsky.social who led the effort.
Aiden Sabadbi, and my amazing colleagues @exai.bio, particularly @fhormozd.bsky.social, @babak-a.bsky.social, and @genophoria.bsky.social who led the effort.
Joining forces with the legendary @babak-a.bsky.social, @fhormozd.bsky.social, and @mkarimzadeh.bsky.social to bring you Exai-1; a multi-modal cell-free RNA foundation model for blood surveillance and liquid biopsy applications. Kudos to the broader @exai.bio team!
www.biorxiv.org/content/10.1...
www.biorxiv.org/content/10.1...
A multi-modal cell-free RNA language model for liquid biopsy applications
Cell-free RNA (cfRNA) profiling has emerged as a powerful tool for non-invasive disease detection, but its application is limited by data sparsity and complexity, especially in settings with constrain...
www.biorxiv.org
April 1, 2025 at 10:29 PM
1/ It has been a privilege to have the opportunity of contributing to Exai-1. Shout out to my co-first author,
Aiden Sabadbi, and my amazing colleagues @exai.bio, particularly @fhormozd.bsky.social, @babak-a.bsky.social, and @genophoria.bsky.social who led the effort.
Aiden Sabadbi, and my amazing colleagues @exai.bio, particularly @fhormozd.bsky.social, @babak-a.bsky.social, and @genophoria.bsky.social who led the effort.
Reposted
Today was a great day! Our paper on using an AI platform for cell-free RNA liquid biopsy is finally published in Nature Communications! Huge thanks to our amazing team at @exai.bio for making this happen! The code is open-source and readily available.
www.nature.com/articles/s41...
www.nature.com/articles/s41...
Deep generative AI models analyzing circulating orphan non-coding RNAs enable detection of early-stage lung cancer - Nature Communications
A generative AI model, Orion, learns a robust and generalizable pattern of non-small cell lung cancer from cancer-specific circulating non-coding RNAs. Orion enhances the performance of liquid biopsy ...
www.nature.com
November 22, 2024 at 12:44 AM
Today was a great day! Our paper on using an AI platform for cell-free RNA liquid biopsy is finally published in Nature Communications! Huge thanks to our amazing team at @exai.bio for making this happen! The code is open-source and readily available.
www.nature.com/articles/s41...
www.nature.com/articles/s41...